{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T04:12:44Z","timestamp":1767154364826,"version":"build-2238731810"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T00:00:00Z","timestamp":1705363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovative Research Team Project of Guangxi  Natural Science Foundation","award":["(Grant No. 2018GXNSFGA281006)"],"award-info":[{"award-number":["(Grant No. 2018GXNSFGA281006)"]}]},{"name":"Guangxi  Natural Science Foundation Project","award":["(Grant No. 2020GXNSFDA297014)"],"award-info":[{"award-number":["(Grant No. 2020GXNSFDA297014)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Intracardiac thrombosis is a severe complication in patients with non-ischemic dilated cardiomyopathy. This study aims to develop and validate an individualized nomogram to evaluate the risk of intracardiac thrombosis in patients with non-ischemic dilated cardiomyopathy. This retrospective study included patients diagnosed with dilated cardiomyopathy at first admission. Clinical baseline characteristics were acquired from electronic medical record systems. Multiple methods were applied to screen the key variables and generate multiple different variable combinations. Multivariable logistic regression was used to build the models, and the optimal model was chosen by comparing the discrimination. Then we checked the performance of the model in different thrombus subgroups. Finally, the model was presented using a nomogram and evaluated from the perspectives of discrimination, calibration, and clinical usefulness. Internal validation was performed by extracting different proportions of data for Bootstrapping. Ultimately, 564 eligible patients were enrolled, 67 of whom developed an intracardiac thrombosis. Risk factors included d-dimer, white blood cell count, high-sensitivity C-reactive protein, pulse pressure, history of stroke, hematocrit, and NT-proBNP in the optimal model. The model had good discrimination and calibration, and the area under the curve (AUC) was 0.833 (0.782\u20130.884), and the model\u2019s performance in each subgroup was stable. Clinical decision curve analysis showed that the model had clinical application value when the high-risk threshold was between 2% and 78%. The AUC of interval validation (30% and 70% data resampling) was 0.844 (0.765\u20130.924) and 0.833 (0.775\u20130.891), respectively. This novel intracardiac thrombosis nomogram could be conveniently applied to facilitate the individual intracardiac thrombosis risk assessment in patients with non-ischemic dilated cardiomyopathy.<\/jats:p>","DOI":"10.1038\/s41598-024-51745-w","type":"journal-article","created":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T14:02:31Z","timestamp":1705413751000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development and validation of a risk model for intracardiac thrombosis in patients with dilated cardiomyopathy: a retrospective study"],"prefix":"10.1038","volume":"14","author":[{"given":"Yuan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long-Chang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Gui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,1,16]]},"reference":[{"issue":"3","key":"51745_CR1","first-page":"157","volume":"47","author":"M Mazzone","year":"2005","unstructured":"Mazzone, M. et al. Review of dilated cardiomyopathies. Dilated cardiomyopathies and altered prothrombotic state: A point of view of the literature. Panminerva Med. 47(3), 157\u2013167 (2005).","journal-title":"Panminerva Med."},{"issue":"2","key":"51745_CR2","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/ehf2.13211","volume":"8","author":"AI Lemaitre","year":"2021","unstructured":"Lemaitre, A. I. et al. Clinical profile and midterm prognosis of left ventricular thrombus in heart failure. ESC Heart Fail. 8(2), 1333\u20131341 (2021).","journal-title":"ESC Heart Fail."},{"issue":"05","key":"51745_CR3","first-page":"421","volume":"34","author":"Cardiology CSo","year":"2018","unstructured":"Cardiology CSo, Group Cmcc. Chinese guidelines for diagnosis and treatment of dilated cardiomyopathy. J. Clin. Cardiol. 34(05), 421\u2013434 (2018).","journal-title":"J. Clin. Cardiol."},{"issue":"8","key":"51745_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski, P. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 18(8), 891\u2013975 (2016).","journal-title":"Eur. J. Heart Fail."},{"key":"51745_CR5","doi-asserted-by":"crossref","unstructured":"Correction to: Current diagnostic and treatment strategies for specific dilated cardiomyopathies: A scientific statement from the American Heart Association. Circulation 134(23), e652 (2016).","DOI":"10.1161\/CIR.0000000000000474"},{"issue":"7","key":"51745_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.21037\/atm.2016.03.35","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z. Variable selection with stepwise and best subset approaches. Ann. Transl. Med. 4(7), 136 (2016).","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"51745_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","volume":"33","author":"J Friedman","year":"2010","unstructured":"Friedman, J., Hastie, T. & Tibshirani, R. Regularization paths for generalized linear models via coordinate descent. J. Stat. Softw. 33(1), 1\u201322 (2010).","journal-title":"J. Stat. Softw."},{"issue":"6","key":"51745_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B Van Calster","year":"2018","unstructured":"Van Calster, B. et al. Reporting and interpreting decision curve analysis: A guide for investigators. Eur. Urol. 74(6), 796\u2013804 (2018).","journal-title":"Eur. Urol."},{"issue":"21","key":"51745_CR9","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1200\/JCO.2015.65.5654","volume":"34","author":"KF Kerr","year":"2016","unstructured":"Kerr, K. F., Brown, M. D., Zhu, K. & Janes, H. Assessing the clinical impact of risk prediction models with decision curves: Guidance for correct interpretation and appropriate use. J. Clin. Oncol. 34(21), 2534\u20132540 (2016).","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"51745_CR10","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJMra0801082","volume":"359","author":"B Furie","year":"2008","unstructured":"Furie, B. & Furie, B. C. Mechanisms of thrombus formation. N. Engl. J. Med. 359(9), 938\u2013949 (2008).","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"51745_CR11","first-page":"785","volume":"38","author":"M Koupenova","year":"2017","unstructured":"Koupenova, M., Kehrel, B. E., Corkrey, H. A. & Freedman, J. E. Thrombosis and platelets: An update. Eur. Heart J. 38(11), 785\u2013791 (2017).","journal-title":"Eur. Heart J."},{"issue":"2","key":"51745_CR12","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1378\/chest.117.2.314","volume":"117","author":"ND Sharma","year":"2000","unstructured":"Sharma, N. D., McCullough, P. A., Philbin, E. F. & Weaver, W. D. Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest 117(2), 314\u2013320 (2000).","journal-title":"Chest"},{"issue":"15","key":"51745_CR13","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1016\/j.jacc.2019.01.031","volume":"73","author":"CP McCarthy","year":"2019","unstructured":"McCarthy, C. P. et al. Left ventricular thrombus: Contemporary etiologies, treatment strategies, and outcomes. J. Am. Coll. Cardiol. 73(15), 2007\u20132009 (2019).","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"51745_CR14","doi-asserted-by":"publisher","first-page":"H405","DOI":"10.1152\/ajpheart.00133.2019","volume":"317","author":"DR Prows","year":"2019","unstructured":"Prows, D. R., Klingler, A., Gibbons, W. J. Jr., Homan, S. M. & Zimmermann, N. Characterization of a mouse model of hypereosinophilia-associated heart disease. Am. J. Physiol. Heart Circ. Physiol. 317(2), H405\u2013H414 (2019).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"7","key":"51745_CR15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1182\/bloodadvances.2020001500","volume":"4","author":"C Valladolid","year":"2020","unstructured":"Valladolid, C. et al. Modulating the rate of fibrin formation and clot structure attenuates microvascular thrombosis in systemic inflammation. Blood Adv. 4(7), 1340\u20131349 (2020).","journal-title":"Blood Adv."},{"issue":"17","key":"51745_CR16","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1136\/heartjnl-2018-314381","volume":"105","author":"SAS Beggs","year":"2019","unstructured":"Beggs, S. A. S., Rorth, R., Gardner, R. S. & McMurray, J. J. V. Anticoagulation therapy in heart failure and sinus rhythm: A systematic review and meta-analysis. Heart 105(17), 1325\u20131334 (2019).","journal-title":"Heart"},{"issue":"5","key":"51745_CR17","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ijcard.2012.12.018","volume":"167","author":"F Zannad","year":"2013","unstructured":"Zannad, F. et al. Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges. Int. J. Cardiol. 167(5), 1772\u20131782 (2013).","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"51745_CR18","first-page":"561","volume":"64","author":"JM Higgins","year":"2019","unstructured":"Higgins, J. M., San, C., Lagnado, G., Chua, D. & Mihic, T. Incidence and management of clozapine-induced myocarditis in a large tertiary hospital. Can. J. Psychiatry 64(8), 561\u2013567 (2019).","journal-title":"Can. J. Psychiatry"},{"issue":"4","key":"51745_CR19","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1161\/01.STR.0000260090.90508.3e","volume":"38","author":"GY Lip","year":"2007","unstructured":"Lip, G. Y., Patel, J. V., Hughes, E. & Hart, R. G. High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: Relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 38(4), 1229\u20131237 (2007).","journal-title":"Stroke"},{"issue":"1","key":"51745_CR20","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2008.12.052","volume":"142","author":"C Cianfrocca","year":"2010","unstructured":"Cianfrocca, C. et al. C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation. Int. J. Cardiol. 142(1), 22\u201328 (2010).","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"51745_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ijcard.2011.02.020","volume":"159","author":"S Ederhy","year":"2012","unstructured":"Ederhy, S. et al. C-reactive protein and transesophageal echocardiographic markers of thromboembolism in patients with atrial fibrillation. Int. J. Cardiol. 159(1), 40\u201346 (2012).","journal-title":"Int. J. Cardiol."},{"issue":"33","key":"51745_CR22","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","volume":"34","author":"AL Caforio","year":"2013","unstructured":"Caforio, A. L. et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 34(33), 2636\u20132648 (2013).","journal-title":"Eur. Heart J."},{"issue":"14","key":"51745_CR23","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","volume":"113","author":"BJ Maron","year":"2006","unstructured":"Maron, B. J. et al. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14), 1807\u20131816 (2006).","journal-title":"Circulation"},{"issue":"2","key":"51745_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.CIR.66.2.355","volume":"66","author":"A Matsumori","year":"1982","unstructured":"Matsumori, A. & Kawai, C. An animal model of congestive (dilated) cardiomyopathy: Dilatation and hypertrophy of the heart in the chronic stage in DBA\/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation 66(2), 355\u2013360 (1982).","journal-title":"Circulation"},{"issue":"11","key":"51745_CR25","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1253\/jcj.46.1192","volume":"46","author":"A Matsumori","year":"1982","unstructured":"Matsumori, A., Kawai, C. & Sawada, S. Encephalomyocarditis virus myocarditis in inbred strains of mice\u2013chronic stage. Jpn. Circ. J. 46(11), 1192\u20131196 (1982).","journal-title":"Jpn. Circ. J."},{"issue":"1","key":"51745_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/01.moh.0000190107.54790.de","volume":"13","author":"V Afshar-Kharghan","year":"2006","unstructured":"Afshar-Kharghan, V. & Thiagarajan, P. Leukocyte adhesion and thrombosis. Curr. Opin. Hematol. 13(1), 34\u201339 (2006).","journal-title":"Curr. Opin. Hematol."},{"issue":"9","key":"51745_CR27","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1111\/jth.12646","volume":"12","author":"F Violi","year":"2014","unstructured":"Violi, F., Cangemi, R. & Calvieri, C. Pneumonia, thrombosis and vascular disease. J. Thromb. Haemost. 12(9), 1391\u20131400 (2014).","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"51745_CR28","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann, B. & Massberg, S. Thrombosis as an intravascular effector of innate immunity. Nat. Rev. Immunol. 13(1), 34\u201345 (2013).","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"51745_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1055\/s-2007-996133","volume":"23","author":"SM Jafri","year":"1997","unstructured":"Jafri, S. M. Hypercoagulability in heart failure. Semin. Thromb. Hemost. 23(6), 543\u2013545 (1997).","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"51745_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00392-019-01522-x","volume":"109","author":"PT Matusik","year":"2020","unstructured":"Matusik, P. T., Malecka, B., Lelakowski, J. & Undas, A. Association of NT-proBNP and GDF-15 with markers of a prothrombotic state in patients with atrial fibrillation off anticoagulation. Clin. Res. Cardiol. 109(4), 426\u2013434 (2020).","journal-title":"Clin. Res. Cardiol."},{"issue":"7","key":"51745_CR31","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ajh.25482","volume":"94","author":"ED Johnson","year":"2019","unstructured":"Johnson, E. D., Schell, J. C. & Rodgers, G. M. The D-dimer assay. Am. J. Hematol. 94(7), 833\u2013839 (2019).","journal-title":"Am. J. Hematol."},{"key":"51745_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acc.2014.12.001","volume":"69","author":"JD Olson","year":"2015","unstructured":"Olson, J. D. D-dimer: An overview of hemostasis and fibrinolysis, assays, and clinical applications. Adv. Clin. Chem. 69, 1\u201346 (2015).","journal-title":"Adv. Clin. Chem."},{"issue":"1","key":"51745_CR33","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1161\/STROKEAHA.115.011035","volume":"47","author":"AR Folsom","year":"2016","unstructured":"Folsom, A. R., Gottesman, R. F., Appiah, D., Shahar, E. & Mosley, T. H. Plasma d-dimer and incident ischemic stroke and coronary heart disease: The atherosclerosis risk in communities study. Stroke 47(1), 18\u201323 (2016).","journal-title":"Stroke"},{"key":"51745_CR34","doi-asserted-by":"publisher","first-page":"111437","DOI":"10.1016\/j.bios.2019.111437","volume":"141","author":"J Li","year":"2019","unstructured":"Li, J. et al. Quantitative detection and evaluation of thrombus formation based on electrical impedance spectroscopy. Biosens. Bioelectron. 141, 111437 (2019).","journal-title":"Biosens. Bioelectron."},{"issue":"7","key":"51745_CR35","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1001\/jamacardio.2018.1086","volume":"3","author":"CP McCarthy","year":"2018","unstructured":"McCarthy, C. P. et al. Left ventricular thrombus after acute myocardial infarction: Screening, prevention, and treatment. JAMA Cardiol. 3(7), 642\u2013649 (2018).","journal-title":"JAMA Cardiol."},{"issue":"4","key":"51745_CR36","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/joim.12944","volume":"286","author":"D Reichart","year":"2019","unstructured":"Reichart, D., Magnussen, C., Zeller, T. & Blankenberg, S. Dilated cardiomyopathy: From epidemiologic to genetic phenotypes: A translational review of current literature. J. Intern. Med. 286(4), 362\u2013372 (2019).","journal-title":"J. Intern. Med."},{"issue":"11","key":"51745_CR37","first-page":"997","volume":"130","author":"W Elikowski","year":"2020","unstructured":"Elikowski, W., Malek-Elikowska, M., Fertala, N. & Zawodna-Marszalek, M. Multichamber intracardiac thrombi successfully treated with apixaban in a patient with dilated cardiomyopathy and sinus rhythm. Pol. Arch. Intern. Med. 130(11), 997\u2013999 (2020).","journal-title":"Pol. Arch. Intern. Med."},{"issue":"4","key":"51745_CR38","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/S1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran, V. P., Gonen, M., Smith, J. J. & DeMatteo, R. P. Nomograms in oncology: More than meets the eye. Lancet Oncol. 16(4), e173\u2013e180 (2015).","journal-title":"Lancet Oncol."},{"issue":"1","key":"51745_CR39","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1159\/000047342","volume":"95","author":"D Paydarfar","year":"2001","unstructured":"Paydarfar, D. et al. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: Distinct features of subacute thrombi. Cardiology 95(1), 40\u201347 (2001).","journal-title":"Cardiology"},{"issue":"18","key":"51745_CR40","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang, Y. Q. et al. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J. Clin. Oncol. 34(18), 2157\u20132164 (2016).","journal-title":"J. Clin. Oncol."}],"updated-by":[{"DOI":"10.1038\/s41598-024-59433-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51745-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51745-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T11:36:37Z","timestamp":1713267397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-51745-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,16]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51745"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-51745-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,16]]},"assertion":[{"value":"15 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-59433-5","URL":"https:\/\/doi.org\/10.1038\/s41598-024-59433-5","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1431"}}